Adrian L. Lopresti

Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study

Adrian L. Lopresti, Michaël Maes, Garth Maker et al. · Journal of Affective Disorders · 2014 · 203 citations

Psychiatry, Mood Symptom, Medicine +7

An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract

Adrian L. Lopresti, Stephen J. Smith, Hakeemudin Malvi et al. · Medicine · 2019 · 189 citations · Full text

Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study

Adrian L. Lopresti, Peter D. Drummond · Journal of Affective Disorders · 2016 · 164 citations

Psychiatry, Mood Symptom, Pharmacology +8

Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change

Adrian L. Lopresti, Michaël Maes, M J Meddens et al. · European Neuropsychopharmacology · 2014 · 96 citations

Psychiatry, Mood Symptom, Medicine +11

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (<i>Withania somnifera</i>) in Aging, Overweight Males

Adrian L. Lopresti, Peter D. Drummond, Stephen J. Smith · American Journal of Men s Health · 2019 · 83 citations · Full text

Aging, Youthful Vigor, Short Form +27